MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. (Q40198585)
Jump to navigation
Jump to search
scientific article published on 24 May 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. |
scientific article published on 24 May 2017 |
Statements
MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis (English)
Guohua Lou
Ying Yang
Feifei Liu
Bingjue Ye
Zhi Chen
1 reference